Vemurafenib-Induced Radiation Recall Dermatitis: Case Report and Review of the Literature
- 29 November 2014
- journal article
- case report
- Published by S. Karger AG in Dermatology
- Vol. 230 (1), 1-4
- https://doi.org/10.1159/000365918
Abstract
The cutaneous effects of BRAF (serine/threonine protein kinase B-raf) inhibitors such as vemurafenib remain poorly defined. Rash, squamous cell carcinoma, keratoacanthoma and photosensitivity are the most common grade 2 or 3 adverse events observed in clinical trials. We here report the case of a patient with a BRAF V600E mutated metastatic melanoma who developed severe radiation recall dermatitis 6 weeks after completing radiotherapy. Vemurafenib treatment had been initiated 1 week before the development of dermatitis because of rapidly progressing disease. Upon topical treatment of the affected skin areas, clinical symptoms regressed over a period of 2 months, although vemurafenib was continuously administered. As our case goes in line with other reports, we believe that physicians should be aware of this additional cutaneous side effect of vemurafenib and that continuation of the treatment is safe when close clinical control and interdisciplinary management can be provided.Keywords
This publication has 22 references indexed in Scilit:
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Radiation recall dermatitis induced by erlotinibJournal of the American Academy of Dermatology, 2009
- Distinct Sets of Genetic Alterations in MelanomaNew England Journal of Medicine, 2005
- Management of Cutaneous MelanomaNew England Journal of Medicine, 2004
- Radiation Recall: Another Call With TamoxifenActa Oncologica, 1999
- Radiation reaction recall following simvastatin therapy: A new observationClinical Oncology, 1995
- High Yields of Lethal Mutations in Somatic Mammalian Cells that Survive Ionizing RadiationInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1986
- Stem cell depletion: An explanation of the late effects of cytotoxinsInternational Journal of Radiation Oncology*Biology*Physics, 1977
- Complications of irradiation related to apparent drug potentiation by adriamycinInternational Journal of Radiation Oncology*Biology*Physics, 1976